Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller......

Bharat Biotech to make 900 million Covaxin vaccines

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......

Govt exploring possibility to produce Covaxin abroad

To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously......

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up......